This 2-day conference organised by the Champalimaud Foundation, in partnership with Faculdade de Motricidade Humana, will provide an overview of the scientific landscape in the area of physical activity and cancer, from prevention to rehabilitation and survivorship.

These are exciting times for research in this space as physical activity becomes more widely recognised as a powerful partner in the prevention and treatment of cancer.

O Centro Clínico Champalimaud pretende admitir um(a) Médico(a) especialista em Dermatologista, para integrar a Unidade de Dermatologia dedicada em exclusividade ao Cancro da Pele.

O Centro Clínico pretende admitir em regime de tempo completo e dedicação plena.

With fully functional inpatient and recovery units, as well as operating rooms, the Centre is now prepared to significantly expand the Champalimaud Foundation's capacity to treat pancreatic cancer patients. With a dedicated team of specialists in the treatment and research of this type of cancer, the Centre's mission is to deliver the highest standard of clinical care.

Natural ageing is one of the main risk factors for cancer. As we become older, the probability of developing cancer increases. This happens, on the one hand, because the probability of acquiring cancer-causing mutations grows as we live longer; and on the other, because our DNA repair mechanisms decline with age.

Host

Carlos Minutti, PhD, Immunoregulation Lab 

Venue

Seminar room

Host

Carlos Minnutti, Group Leader at Champalimaud Research

Venue

Seminar room

The ERC Starting Grant is one of Europe’s most prestigious and competitive research awards, designed to support promising early-career researchers who have the potential to become leaders in their fields. Ianuş will receive €2M over the next five years to develop her research project at King’s College London, where she recently joined as a Lecturer in Healthcare Engineering.

Here are some recurrent unproven claims:

Using zebrafish “Avatars”, an animal model developed by the Cancer Development and Innate Immune Evasion lab at the Champalimaud Foundation (CF), led by Rita Fior, Mayra Martínez-López – a former PhD student at the lab now working at the Universidad de las Américas in Quito, Ecuador – and colleagues studied the initial steps of the Bacillus Calmette-Guérin (BCG) vaccine’s action on bladder cancer cells.

The Champalimaud Clinical Centre intends to admit a newly qualified specialist in gastroenterology, with a maximum of 24 months of specialist, and who seeks to develop interventional endoscopy skills, in all the range of its techniques, including the biliopancreatic area, but also with a focus on the resection of early lesions, echoendoscopy and palliative approaches. 
 
The Champalimaud Clinical Center intends to admit on a full-time basis and full dedication.